Unicycive Therapeutics, Inc. (UNCY) quarterly balance sheet — complete assets, liabilities & equity history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Total Current Assets | 63.55M | 48.96M | 50.29M | 29.53M | 27.35M | 30.95M | 37.74M | 44.05M | 51.68M | 13.4M | 18.57M | 21.93M | 26.18M | 2.64M | 9.96M | 12.56M | 15.46M | 18.41M | 19.78M | 913K |
| Cash & Short-Term Investments | 54.59M | 41.27M | 42.7M | 22.33M | 19.77M | 26.14M | 32.35M | 41.78M | 48.93M | 9.7M | 14.35M | 18.82M | 24.33M | 455K | 7.01M | 10.57M | 13.62M | 16.58M | 18.01M | 1K |
| Cash Only | 37.37M | 29.2M | 42.7M | 22.33M | 19.77M | 26.14M | 32.35M | 41.78M | 48.93M | 9.7M | 14.35M | 18.82M | 24.33M | 455K | 7.01M | 10.57M | 13.62M | 16.58M | 18.01M | 1K |
| Short-Term Investments | 17.21M | 12.07M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 8.96M | 7.69M | 7.59M | 840K | 1.37M | 939K | 687K | 594K | 503K | 325K | 682K | 320K | 319K | 159K | 69K | 104K | 137K | 126K | 1.71M | 864K |
| Total Non-Current Assets | 861K | 174K | 324K | 469K | 601K | 720K | 833K | 647K | 709K | 792K | 873K | 953K | 1.02M | 174K | 215K | 256K | 296K | 333K | 0 | 864K |
| Property, Plant & Equipment | 861K | 174K | 324K | 469K | 601K | 720K | 833K | 647K | 709K | 792K | 873K | 953K | 1.02M | 174K | 215K | 256K | 296K | 333K | 0 | 0 |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - | 1.13x | - | 4.04x | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 864K |
| Total Assets | 64.41M | 49.13M | 50.61M | 30M | 27.95M | 31.67M | 38.57M | 44.7M | 52.38M | 14.19M | 19.44M | 22.88M | 27.2M | 2.82M | 10.18M | 12.82M | 15.76M | 18.74M | 19.78M | 913K |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - | 0.04x | - | 0.08x | - | - | - | - | - |
| Asset Growth % | 130.46% | 55.16% | 31.2% | -32.9% | -46.65% | 123.16% | 98.41% | 95.35% | 92.58% | 403.58% | 91.04% | 78.55% | 72.6% | -84.97% | -48.55% | 1303.72% | 2972.12% | 9088.24% | 8932.88% | 3160.71% |
| Total Current Liabilities | 26.48M | 18.94M | 13.13M | 13.57M | 16.68M | 24.12M | 10.46M | 13.09M | 30.28M | 17.53M | 15.46M | 15.42M | 15.97M | 3.28M | 5.52M | 2.83M | 2.4M | 2.1M | 785K | 5.12M |
| Accounts Payable | 1.14M | 383K | 957K | 708K | 1.25M | 966K | 548K | 1.38M | 1.17M | 821K | 990K | 503K | 610K | 846K | 2.22M | 699K | 589K | 742K | 43K | 357K |
| Days Payables Outstanding | 324.81 | - | - | - | - | - | - | - | 319.14 | - | - | - | - | - | - | - | - | - | - | - |
| Short-Term Debt | 598K | 117K | 240K | 67K | 146K | 92K | 0 | 0 | 0 | 18K | 0 | 0 | 0 | 46K | 0 | 48K | 27K | 29K | 109K | 4.12M |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 24.75M | 18.44M | 11.67M | 10.21M | 10.59M | 18.94M | 6.38M | 8.23M | 25.01M | 13.13M | 11.62M | 12.92M | 13.39M | 0 | 76K | 0 | -27K | -29K | 0 | -23K |
| Current Ratio | 2.40x | 2.59x | 3.83x | 2.18x | 1.64x | 1.28x | 3.61x | 3.37x | 1.71x | 0.76x | 1.20x | 1.42x | 1.64x | 0.81x | 1.80x | 4.43x | 6.44x | 8.75x | 25.20x | 0.18x |
| Quick Ratio | 2.40x | 2.59x | 3.83x | 2.18x | 1.64x | 1.28x | 3.61x | 3.37x | 1.71x | 0.76x | 1.20x | 1.42x | 1.64x | 0.81x | 1.80x | 4.43x | 6.44x | 8.75x | 25.20x | 0.18x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 217K | 0 | 0 | 0 | 0 | 117K | 265K | 274K | 372K | 466K | 552K | 634K | 715K | 0 | 29K | 72K | 114K | 155K | 0 | 0 |
| Long-Term Debt | 217K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 117K | 265K | 274K | 372K | 466K | 552K | 634K | 715K | 0 | 29K | 72K | 114K | 155K | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 26.7M | 18.94M | 13.13M | 13.57M | 16.68M | 24.24M | 10.72M | 13.36M | 30.65M | 18M | 16.01M | 16.05M | 16.68M | 3.28M | 5.55M | 2.91M | 2.52M | 2.26M | 785K | 5.12M |
| Total Debt | 815K | 117K | 505K | 476K | 694K | 773K | 807K | 634K | 715K | 811K | 866K | 937K | 991K | 201K | 194K | 280K | 296K | 335K | 109K | 4.12M |
| Net Debt | -36.56M | -29.08M | -42.19M | -21.85M | -19.07M | -25.37M | -31.54M | -41.15M | -48.22M | -8.89M | -13.48M | -17.88M | -23.34M | -254K | -6.82M | -10.29M | -13.32M | -16.24M | -17.9M | 4.12M |
| Debt / Equity | 0.02x | 0.00x | 0.01x | 0.03x | 0.06x | 0.10x | 0.03x | 0.02x | 0.03x | - | 0.25x | 0.14x | 0.09x | - | 0.04x | 0.03x | 0.02x | 0.02x | 0.01x | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | -542.26x | -399.73x | -494.92x | 39.00x | -463.05x | -272.07x | -462.56x | -1047.15x | -332.26x | -239.72x | -118.94x | -1213.58x | -1775.00x | -1851.33x | - | - | - | -93.56x | -2.43x |
| Total Equity | 37.7M | 30.2M | 37.48M | 16.43M | 11.27M | 7.43M | 27.85M | 31.34M | 21.73M | -3.81M | 3.43M | 6.83M | 10.52M | -466K | 4.63M | 9.91M | 13.24M | 16.48M | 19M | -4.2M |
| Equity Growth % | 234.52% | 306.37% | 34.58% | -47.58% | -48.13% | 295.09% | 711.01% | 358.87% | 106.63% | -717.38% | -25.77% | -31.08% | -20.59% | -102.83% | -75.65% | 335.84% | 489.3% | 717.15% | 1120.8% | -222.49% |
| Book Value per Share | 0.16 | 0.19 | 2.07 | 1.34 | 0.91 | 1.11 | 3.13 | 3.33 | 6.22 | -1.10 | 1.05 | 4.48 | 6.90 | -0.31 | 3.07 | 6.59 | 8.82 | 11.64 | 1.34 | -3.01 |
| Total Shareholders' Equity | 37.7M | 30.2M | 37.48M | 16.43M | 11.27M | 7.43M | 27.85M | 31.34M | 21.73M | -3.81M | 3.43M | 6.83M | 10.52M | -466K | 4.63M | 9.91M | 13.24M | 16.48M | 19M | -4.2M |
| Common Stock | 25K | 22K | 21K | 122K | 120K | 114K | 98K | 43K | 37K | 35K | 35K | 15K | 15K | 15K | 15K | 15K | 15K | 15K | 15K | 9K |
| Retained Earnings | -140.65M | -127.83M | -113.16M | -107.15M | -100.7M | -101.27M | -79.75M | -75.65M | -85.5M | -64.54M | -56.74M | -52.41M | -48.57M | -34M | -28.67M | -23.11M | -19.48M | -15.94M | -13.19M | -7.99M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 6K | -1K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |